Arkolith/Insider Trading/FBRX/Form 4

Wagner Paul A.

See Remarks, DirectorForte Biosciences, Inc. (FBRX) · full profile →Form 4 · filed Dec 19, 2022
Net Buying
Open-Market Buys
$105K
Open-Market Sells
$0
Net Open-Market Flow
$105K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 16, 2022Buy(P)44K$1.07$47K1.4M
Dec 15, 2022Buy(P)56K$1.03$58K1.3M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-061903) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Forte Biosciences, Inc.

Build

Ask your agent about FBRX insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001209191-22-061903"
Ask your agent
Use Arkolith to summarize insider buying and selling at Forte Biosciences, Inc.
over the last 90 days and cite the filings.